US Doctors Show Increased Caution in Prescribing Anxiety Medication, Prescription Rates Decline

Roanoke Lynchburg, VA, October 1, 2026 —

Physicians across the United States are exhibiting a notable trend toward increased caution when prescribing anxiety medications, particularly benzodiazepines. This shift in prescribing practices has coincided with a significant decrease in the overall rate of these prescriptions.

Studies indicate that between the years 2013 and 2024, there has been a 26% reduction in the number of benzodiazepine prescriptions issued. This period reflects a growing awareness among healthcare providers regarding the potential risks associated with long-term benzodiazepine use, including dependence, tolerance, and withdrawal symptoms.

Benzodiazepines, a class of psychoactive drugs that include well-known medications like alprazolam (Xanax), diazepam (Valium), and lorazepam (Ativan), are typically prescribed for short-term relief of anxiety disorders, insomnia, and seizures. However, concerns over their addictive potential and side effects have prompted medical professionals to re-evaluate their use.

The observed decline suggests a move towards alternative treatment modalities for anxiety, which may include psychotherapy, lifestyle adjustments, or other classes of medication with potentially lower risks of dependence. The exact reasons or specific studies driving this heightened caution were not detailed in the provided information. Information regarding specific physician groups or institutions leading this trend was also not available.

The trend highlights an evolving approach to mental health treatment, emphasizing a more conservative strategy for managing anxiety disorders. Further details on the specific studies cited or the full scope of physician sentiment are not presently available.

Story summarized from the original created by Amir Massenburg on www.wdbj7.com, see more information here.

Media gallery